These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11357488

  • 1. Comments to: Tarnow L, Kjeld T, Knudsen E et al. (2000) lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 43: 794-799.
    Soltész G, Rózsai B.
    Diabetologia; 2001 Apr; 44(4):520. PubMed ID: 11357488
    [No Abstract] [Full Text] [Related]

  • 2. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L, Kjeld T, Knudsen E, Major-Pedersen A, Parving HH.
    Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
    [Abstract] [Full Text] [Related]

  • 3. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W.
    Przegl Lek; 2000 Jun; 57 Suppl 3():19-24. PubMed ID: 11293230
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetics of diabetic nephropathy.
    Merta M, Reiterova J, Rysavá R, Kmentová D, Tesar V.
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v24-5. PubMed ID: 12817062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control.
    Savage DA, Feeney SA, Fogarty DG, Maxwell AP.
    Nephrol Dial Transplant; 1999 Apr; 14(4):891-4. PubMed ID: 10328465
    [Abstract] [Full Text] [Related]

  • 11. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
    Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F.
    J Clin Invest; 1997 Apr 01; 99(7):1585-95. PubMed ID: 9120002
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Möllsten A, Vionnet N, Forsblom C, Parkkonen M, Tarnow L, Hadjadj S, Marre M, Parving HH, Groop PH.
    Mol Genet Metab; 2011 May 01; 103(1):66-70. PubMed ID: 21316998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The significance of candidate genes' polymorphism in the development of diabetic nephropathy].
    Grzeszczak W, Zukowska-Szczechowska E.
    Wiad Lek; 1998 May 01; 51 Suppl 2():11-23. PubMed ID: 9686528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.